Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
significant arm pain after the first dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of pain in arm in a 45-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (She experiences a case of Shingles a few weeks ago). Concurrent medical conditions included immunocompromised (This patient has immunocompromised). On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: significant arm pain after the first dose). The outcome of the pain in arm was not reported. It was unknown if the reporter considered the pain in arm to be related to Shingrix. It was unknown if the company considered the pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date: 13-JAN-2026 Reporter reported that the pharmacy where she went to get the vaccine did not want to give it to her because she was not over 50 years old. She had a letter from her doctor and a qualifying immunocompromise, so the pharmacy finally administered the first dose of Shingrix. The batch number was not provided, and we are unable to contact the reporter.
Immunocompromised (This patient has immunocompromised)
Medical History/Concurrent Conditions: Shingles (She experiences a case of Shingles a few weeks ago)